Evaluation of Advanced Structure-Based Virtual Screening Methods for Computer-Aided Drug DiscoveryComputational virtual screening has become an essentialplatform of drug discovery for the efficient identification of active candidates.
('Evaluation', 'Evaluation', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Advanced', 'Advanced', 'JJ', 'B-NP', 'O')
('Structure-Based', 'Structure-Based', 'JJ', 'I-NP', 'O')
('Virtual', 'Virtual', 'NNP', 'I-NP', 'O')
('Screening', 'Screening', 'NNP', 'I-NP', 'O')
('Methods', 'Methods', 'NNP', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('Computer-Aided', 'Computer-Aided', 'NNP', 'B-NP', 'O')
('Drug', 'Drug', 'NNP', 'I-NP', 'O')
('Discovery', 'Discovery', 'NNP', 'I-NP', 'O')
('Computational', 'Computational', 'NNP', 'I-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('become', 'become', 'VBN', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('essential', 'essential', 'JJ', 'I-NP', 'O')
('platform', 'platform', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('drug', 'drug', 'NN', 'B-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('efficient', 'efficient', 'JJ', 'I-NP', 'O')
('identification', 'identification', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('active', 'active', 'JJ', 'B-NP', 'O')
('candidates.', 'candidates.', 'NN', 'I-NP', 'O')
Moleculardocking, a key technology of receptor-centric virtual screening, is commonly used to predict the binding affinities of chemical compounds on target receptors.
('Moleculardocking,', 'Moleculardocking,', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('key', 'key', 'JJ', 'I-NP', 'O')
('technology', 'technology', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('receptor-centric', 'receptor-centric', 'JJ', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening,', 'screening,', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('commonly', 'commonly', 'RB', 'I-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('predict', 'predict', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('chemical', 'chemical', 'JJ', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('target', 'target', 'NN', 'B-NP', 'O')
('receptors.', 'receptors.', 'NNS', 'I-NP', 'O')
Despite the advancement and extensive application of these methods, substantial improvement is still required to increase their accuracy and time-efficiency.
('Despite', 'Despite', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('advancement', 'advancement', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('extensive', 'extensive', 'JJ', 'B-NP', 'O')
('application', 'application', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('methods,', 'methods,', 'NN', 'I-NP', 'O')
('substantial', 'substantial', 'JJ', 'I-NP', 'O')
('improvement', 'improvement', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('still', 'still', 'RB', 'I-VP', 'O')
('required', 'require', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('increase', 'increase', 'VB', 'I-VP', 'O')
('their', 'their', 'PRP$', 'B-NP', 'O')
('accuracy', 'accuracy', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('time-efficiency.', 'time-efficiency.', 'NN', 'I-NP', 'O')
Here, we evaluate several advanced structure-based virtual screening approaches for elucidating the rank-order activity of chemi cal libraries, and the quantitative structure­ activity relationship (QSAR).
('Here,', 'Here,', 'RB', 'B-ADVP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('evaluate', 'evaluate', 'VBP', 'B-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('advanced', 'advance', 'VBN', 'I-NP', 'O')
('structure-based', 'structure-based', 'JJ', 'I-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('approaches', 'approach', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('elucidating', 'elucidate', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('rank-order', 'rank-order', 'JJ', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('chemi', 'chemi', 'NN', 'B-NP', 'O')
('cal', 'cal', 'JJ', 'I-NP', 'O')
('libraries,', 'libraries,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('quantitative', 'quantitative', 'JJ', 'I-NP', 'O')
('structure\xad', 'structure\xad', 'NN', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('relationship', 'relationship', 'NN', 'I-NP', 'O')
('(QSAR).', '(QSAR).', 'NN', 'I-NP', 'O')
Our results show that the ensemble-average free energy estimation, induding implicit solvation energy terms, significantly improves the hit enrichment of the virtual screening.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('show', 'show', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ensemble-average', 'ensemble-average', 'JJ', 'I-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('estimation,', 'estimation,', 'NN', 'I-NP', 'O')
('induding', 'indude', 'VBG', 'B-VP', 'O')
('implicit', 'implicit', 'JJ', 'B-NP', 'O')
('solvation', 'solvation', 'NN', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('terms,', 'terms,', 'NN', 'I-NP', 'O')
('significantly', 'significantly', 'RB', 'B-ADVP', 'O')
('improves', 'improve', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('hit', 'hit', 'NN', 'I-NP', 'O')
('enrichment', 'enrichment', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening.', 'screening.', 'NN', 'I-NP', 'O')
We also demonstrate that the assignment of quantum mechanical-polarized (QM-polarized) partial charges to docked ligands contributes to the reproduction of the crystal pose of ligands in the docking and scoring procedure.
('We', 'We', 'PRP', 'B-NP', 'O')
('also', 'also', 'RB', 'B-ADVP', 'O')
('demonstrate', 'demonstrate', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('assignment', 'assignment', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('quantum', 'quantum', 'NN', 'B-NP', 'O')
('mechanical-polarized', 'mechanical-polarized', 'JJ', 'I-NP', 'O')
('(QM-polarized)', '(QM-polarized)', 'NN', 'I-NP', 'O')
('partial', 'partial', 'JJ', 'I-NP', 'O')
('charges', 'charge', 'NNS', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('docked', 'dock', 'VBN', 'B-NP', 'O')
('ligands', 'ligand', 'NNS', 'I-NP', 'O')
('contributes', 'contribute', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('reproduction', 'reproduction', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('crystal', 'crystal', 'JJ', 'I-NP', 'O')
('pose', 'pose', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('ligands', 'ligand', 'NNS', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('procedure.', 'procedure.', 'NN', 'I-NP', 'O')
Che of the major challenges in drug discovery is to identify novel compounds with biological activity.
('Che', 'Che', 'NNP', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('major', 'major', 'JJ', 'I-NP', 'O')
('challenges', 'challenge', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('drug', 'drug', 'NN', 'B-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('novel', 'novel', 'JJ', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('biological', 'biological', 'JJ', 'B-NP', 'O')
('activity.', 'activity.', 'NN', 'I-NP', 'O')
Computer-aided drug discovery technology has become an essential and powerful platform 1br the discovery of new lead compounds, as an alternative from, and complement to experimental approaches.
('Computer-aided', 'Computer-aided', 'JJ', 'B-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('technology', 'technology', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('become', 'become', 'VBN', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('essential', 'essential', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('powerful', 'powerful', 'JJ', 'I-NP', 'O')
('platform', 'platform', 'NN', 'I-NP', 'O')
('1br', '1br', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('new', 'new', 'JJ', 'B-NP', 'O')
('lead', 'lead', 'NN', 'I-NP', 'O')
('compounds,', 'compounds,', 'NN', 'I-NP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('alternative', 'alternative', 'JJ', 'I-NP', 'O')
('from,', 'from,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('complement', 'complement', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('experimental', 'experimental', 'JJ', 'B-NP', 'O')
('approaches.', 'approaches.', 'NNS', 'I-NP', 'O')
As the number of high resolution structuresof potential therapeutic targets and small molecules has grown, the significance of in silico experimental approaches has become increasingly important as demonstrated inrecent studies by making use of public data (Cherkasov et al., 2006; Cleves and Jain, 2006; Yoon et al., 2005a; b).
('As', 'As', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('high', 'high', 'JJ', 'B-NP', 'O')
('resolution', 'resolution', 'NN', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('potential', 'potential', 'JJ', 'B-NP', 'O')
('therapeutic', 'therapeutic', 'JJ', 'I-NP', 'O')
('targets', 'target', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('small', 'small', 'JJ', 'B-NP', 'O')
('molecules', 'molecule', 'NNS', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('grown,', 'grown,', 'VBN', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico', 'silico', 'JJ', 'B-NP', 'O')
('experimental', 'experimental', 'JJ', 'I-NP', 'O')
('approaches', 'approach', 'NNS', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('become', 'become', 'VBN', 'I-VP', 'O')
('increasingly', 'increasingly', 'RB', 'B-ADJP', 'O')
('important', 'important', 'JJ', 'I-ADJP', 'O')
('as', 'as', 'IN', 'B-SBAR', 'O')
('demonstrated', 'demonstrate', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('recent', 'recent', 'JJ', 'B-NP', 'O')
('studies', 'study', 'NNS', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('making', 'make', 'VBG', 'B-VP', 'O')
('use', 'use', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('public', 'public', 'JJ', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('(Cherkasov', '(Cherkasov', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2006;', '2006;', ':', 'O', 'O')
('Cleves', 'Cleves', 'NNP', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Jain,', 'Jain,', 'NNP', 'I-NP', 'O')
('2006;', '2006;', ':', 'O', 'O')
('Yoon', 'Yoon', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2005a;', '2005a;', ':', 'O', 'O')
('b).', 'b).', 'NN', 'B-NP', 'O')
Virtual high-throughput screening (Klebe, 2006; C^rea and Matter, 2004), which is a method to rapidly identify biologically    active    compounds    in    silico, can    be    roughly divided into two categories; ligand-centric and receptor­ centric.
('Virtual', 'Virtual', 'JJ', 'B-NP', 'O')
('high-throughput', 'high-throughput', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('(Klebe,', '(Klebe,', 'NNP', 'I-NP', 'O')
('2006;', '2006;', ':', 'O', 'O')
('C^rea', 'C^rea', 'NNP', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Matter,', 'Matter,', 'NNP', 'B-NP', 'O')
('2004),', '2004),', 'CD', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('rapidly', 'rapidly', 'RB', 'I-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('biologically', 'biologically', 'RB', 'B-NP', 'O')
('active', 'active', 'JJ', 'I-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico,', 'silico,', 'NN', 'B-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('roughly', 'roughly', 'RB', 'I-VP', 'O')
('divided', 'divide', 'VBN', 'I-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('two', 'two', 'CD', 'B-NP', 'O')
('categories;', 'categories;', 'NN', 'I-NP', 'O')
('ligand-centric', 'ligand-centric', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('receptor\xad', 'receptor\xad', 'NN', 'I-NP', 'O')
('centric.', 'centric.', 'NN', 'I-NP', 'O')
Ligand-centric    methods essentially focus on the comparative analysis     of the structural shapes and chemical     complementarities     between     compounds     and known ligands.
('Ligand-centric', 'Ligand-centric', 'JJ', 'B-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('essentially', 'essentially', 'RB', 'B-ADVP', 'O')
('focus', 'focus', 'VB', 'B-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('comparative', 'comparative', 'JJ', 'I-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('structural', 'structural', 'JJ', 'I-NP', 'O')
('shapes', 'shape', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('chemical', 'chemical', 'JJ', 'B-NP', 'O')
('complementarities', 'complementarity', 'NNS', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('compounds', 'compound', 'NNS', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('known', 'know', 'VBN', 'B-VP', 'O')
('ligands.', 'ligands.', 'NN', 'B-NP', 'O')
A knowledge of the experimentally selected active compounds is a prerequisite when using this approach (Stahura and Bajorath, 2004).
('A', 'A', 'DT', 'B-NP', 'O')
('knowledge', 'knowledge', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('experimentally', 'experimentally', 'RB', 'I-NP', 'O')
('selected', 'select', 'VBN', 'I-NP', 'O')
('active', 'active', 'JJ', 'I-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('prerequisite', 'prerequisite', 'NN', 'I-NP', 'O')
('when', 'when', 'WRB', 'B-ADVP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('approach', 'approach', 'NN', 'I-NP', 'O')
('(Stahura', '(Stahura', 'NNP', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Bajorath,', 'Bajorath,', 'NNP', 'B-NP', 'O')
('2004).', '2004).', 'CD', 'I-NP', 'O')
Receptor-centric methods predict the interaction of given compounds with a target receptor, and hence they do not require experimental data about the structure of the ligand.
('Receptor-centric', 'Receptor-centric', 'JJ', 'B-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('predict', 'predict', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('interaction', 'interaction', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('given', 'give', 'VBN', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('receptor,', 'receptor,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('hence', 'hence', 'RB', 'B-ADVP', 'O')
('they', 'they', 'PRP', 'B-NP', 'O')
('do', 'do', 'VBP', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('require', 'require', 'VB', 'I-VP', 'O')
('experimental', 'experimental', 'JJ', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('about', 'about', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('structure', 'structure', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand.', 'ligand.', 'NN', 'I-NP', 'O')
Molecular docking is one of the key methodologiesfor receptor-centric virtual screening.
('Molecular', 'Molecular', 'JJ', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('key', 'key', 'JJ', 'I-NP', 'O')
('methodologiesfor', 'methodologiesfor', 'NN', 'I-NP', 'O')
('receptor-centric', 'receptor-centric', 'JJ', 'I-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening.', 'screening.', 'NN', 'I-NP', 'O')
It is a technique for predicting the best binding mode for a given compound that fits into a target receptor, and evaluating its binding affinity.
('It', 'It', 'PRP', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('technique', 'technique', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('predicting', 'predict', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('best', 'good', 'JJS', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('mode', 'mode', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('given', 'give', 'VBN', 'I-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('fits', 'fit', 'VBZ', 'B-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('receptor,', 'receptor,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('evaluating', 'evaluate', 'VBG', 'B-VP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinity.', 'affinity.', 'NN', 'I-NP', 'O')
The docking approach has become a primary technique used in many drug discovery programs (Kitchen et al., 2004; Sousa et al., 2006).
('The', 'The', 'DT', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('approach', 'approach', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('become', 'become', 'VBN', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('primary', 'primary', 'JJ', 'I-NP', 'O')
('technique', 'technique', 'NN', 'I-NP', 'O')
('used', 'use', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('many', 'many', 'JJ', 'B-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('programs', 'program', 'NNS', 'I-NP', 'O')
('(Kitchen', '(Kitchen', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2004;', '2004;', ':', 'O', 'O')
('Sousa', 'Sousa', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2006).', '2006).', 'CD', 'B-NP', 'O')
The docking process involves a conformational search fora compound which complements a target binding site, with the aim of identify ng the best-matching binding pose.
('The', 'The', 'DT', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('process', 'process', 'NN', 'I-NP', 'O')
('involves', 'involve', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('conformational', 'conformational', 'JJ', 'I-NP', 'O')
('search', 'search', 'NN', 'I-NP', 'O')
('fora', 'fora', 'NN', 'I-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('complements', 'complement', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('site,', 'site,', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('aim', 'aim', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('identify', 'identify', 'NN', 'B-NP', 'O')
('ng', 'ng', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('best-matching', 'best-matching', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('pose.', 'pose.', '.', 'O', 'O')
A common computational strategy is to use a suitable scoring function to theoretically evaluate the binding affinities of thousands of molecules in a compound library for a target protein.
('A', 'A', 'DT', 'B-NP', 'O')
('common', 'common', 'JJ', 'I-NP', 'O')
('computational', 'computational', 'JJ', 'I-NP', 'O')
('strategy', 'strategy', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('use', 'use', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('suitable', 'suitable', 'JJ', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('theoretically', 'theoretically', 'RB', 'I-VP', 'O')
('evaluate', 'evaluate', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('thousands', 'thousand', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('molecules', 'molecule', 'NNS', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('protein.', 'protein.', 'NN', 'I-NP', 'O')
An accurate rank-ordered prediction of the compound binding affinities using the scoring function is an invaluable step.
('An', 'An', 'DT', 'B-NP', 'O')
('accurate', 'accurate', 'JJ', 'I-NP', 'O')
('rank-ordered', 'rank-ordered', 'JJ', 'I-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('invaluable', 'invaluable', 'JJ', 'I-NP', 'O')
('step.', 'step.', 'NN', 'I-NP', 'O')
Most of scoring functions used in docking programs are designed to predict binding affinity by evaluating the interaction between a compound and a receptor.
('Most', 'Most', 'JJS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('scoring', 'score', 'VBG', 'B-VP', 'O')
('functions', 'function', 'NNS', 'B-NP', 'O')
('used', 'use', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('docking', 'docking', 'NN', 'B-NP', 'O')
('programs', 'program', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('designed', 'design', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('predict', 'predict', 'VB', 'I-VP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('affinity', 'affinity', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('evaluating', 'evaluate', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('interaction', 'interaction', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('receptor.', 'receptor.', 'NN', 'I-NP', 'O')
However, it should be noted that ligand­ receptor recognition process is determined not only by enthalpic effects but also by entropic effects.
('However,', 'However,', 'WRB', 'B-ADVP', 'O')
('it', 'it', 'PRP', 'B-NP', 'O')
('should', 'should', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('noted', 'note', 'VBN', 'I-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('ligand\xad', 'ligand\xad', 'NN', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('recognition', 'recognition', 'NN', 'I-NP', 'O')
('process', 'process', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('determined', 'determine', 'VBN', 'I-VP', 'O')
('not', 'not', 'RB', 'B-CONJP', 'O')
('only', 'only', 'RB', 'I-CONJP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('enthalpic', 'enthalpic', 'JJ', 'B-NP', 'O')
('effects', 'effect', 'NNS', 'I-NP', 'O')
('but', 'but', 'CC', 'B-CONJP', 'O')
('also', 'also', 'RB', 'I-CONJP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('entropic', 'entropic', 'JJ', 'B-NP', 'O')
('effects.', 'effects.', 'NNS', 'I-NP', 'O')
Moreover, the scoring functions have a simplified form for the energy function to facilitate high-throughput evaluation of a large number of compounds in a single docking run.
('Moreover,', 'Moreover,', 'JJR', 'B-NP', 'O')
('the', 'the', 'DT', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('functions', 'function', 'NNS', 'I-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('simplified', 'simplified', 'JJ', 'I-NP', 'O')
('form', 'form', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('facilitate', 'facilitate', 'VB', 'I-VP', 'O')
('high-throughput', 'high-throughput', 'JJ', 'B-NP', 'O')
('evaluation', 'evaluation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('large', 'large', 'JJ', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('compounds', 'compound', 'NNS', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('single', 'single', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('run.', 'run.', 'NN', 'I-NP', 'O')
These functions may be problematic when used with contemporary docking programs, and can result in a decrease of virtual screening    accuracy.
('These', 'These', 'DT', 'B-NP', 'O')
('functions', 'function', 'NNS', 'I-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('problematic', 'problematic', 'JJ', 'B-ADJP', 'O')
('when', 'when', 'WRB', 'B-ADVP', 'O')
('used', 'use', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('contemporary', 'contemporary', 'JJ', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('programs,', 'programs,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('result', 'result', 'VB', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('decrease', 'decrease', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('virtual', 'virtual', 'JJ', 'B-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('accuracy.', 'accuracy.', 'NN', 'I-NP', 'O')
To    overcome    this    problem,    more precise but time-consuming    computational    methodologies are necessary.
('To', 'To', 'TO', 'B-VP', 'O')
('overcome', 'overcome', 'VB', 'I-VP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('problem,', 'problem,', 'NN', 'I-NP', 'O')
('more', 'more', 'RBR', 'B-NP', 'O')
('precise', 'precise', 'JJ', 'I-NP', 'O')
('but', 'but', 'CC', 'I-NP', 'O')
('time-consuming', 'time-consuming', 'JJ', 'I-NP', 'O')
('computational', 'computational', 'JJ', 'I-NP', 'O')
('methodologies', 'methodology', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('necessary.', 'necessary.', 'JJ', 'B-ADJP', 'O')
There have been a number of reports evaluating the efficiency of various virtual screening approaches, including the evaluation of docking programs (Warren et al, 2006), machine-learning methods for ligand-based descriptors(Chen et al., 2007) and comparison of shape-matching with docking (Hawkins et al., 2007).
('There', 'There', 'EX', 'B-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('reports', 'report', 'NNS', 'B-NP', 'O')
('evaluating', 'evaluate', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('approaches,', 'approaches,', 'NN', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('evaluation', 'evaluation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('docking', 'docking', 'NN', 'B-NP', 'O')
('programs', 'program', 'NNS', 'I-NP', 'O')
('(Warren', '(Warren', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al,', 'al,', 'NN', 'I-NP', 'O')
('2006),', '2006),', 'VBD', 'B-VP', 'O')
('machine-learning', 'machine-learning', 'JJ', 'B-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ligand-based', 'ligand-based', 'JJ', 'B-NP', 'O')
('descriptors', 'descriptor', 'NNS', 'I-NP', 'O')
('(Chen', '(Chen', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2007)', '2007)', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('comparison', 'comparison', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('shape-matching', 'shape-matching', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('docking', 'docking', 'NN', 'B-NP', 'O')
('(Hawkins', '(Hawkins', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2007).', '2007).', 'CD', 'B-NP', 'O')
Here, we describe and evaluate several receptor-centric computational methodologies which are applicable for use in drug discovery applications.
('Here,', 'Here,', 'RB', 'B-ADVP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('describe', 'describe', 'VBP', 'B-VP', 'O')
('and', 'and', 'CC', 'I-VP', 'O')
('evaluate', 'evaluate', 'VBP', 'I-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('receptor-centric', 'receptor-centric', 'JJ', 'I-NP', 'O')
('computational', 'computational', 'JJ', 'I-NP', 'O')
('methodologies', 'methodology', 'NNS', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('applicable', 'applicable', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('use', 'use', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('drug', 'drug', 'NN', 'B-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('applications.', 'applications.', 'NN', 'I-NP', 'O')
We focus on accurate docking and rank-ordering for the improvement    of    the    predictability    of    biologically    active compounds.
('We', 'We', 'PRP', 'B-NP', 'O')
('focus', 'focus', 'VBP', 'B-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('accurate', 'accurate', 'JJ', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('rank-ordering', 'rank-ordering', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('improvement', 'improvement', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('predictability', 'predictability', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('biologically', 'biologically', 'RB', 'B-NP', 'O')
('active', 'active', 'JJ', 'I-NP', 'O')
('compounds.', 'compounds.', 'NN', 'I-NP', 'O')
We    applied    several    computational    solutions    from    theSchrodinger      software      package      (Schrodinger,      LLC: Portland, OR).
('We', 'We', 'PRP', 'B-NP', 'O')
('applied', 'apply', 'VBD', 'B-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('computational', 'computational', 'JJ', 'I-NP', 'O')
('solutions', 'solution', 'NNS', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Schrodinger', 'Schrodinger', 'NNP', 'I-NP', 'O')
('software', 'software', 'NN', 'I-NP', 'O')
('package', 'package', 'NN', 'I-NP', 'O')
('(Schrodinger,', '(Schrodinger,', 'NNP', 'I-NP', 'O')
('LLC:', 'LLC:', 'NNP', 'I-NP', 'O')
('Portland,', 'Portland,', 'NNP', 'I-NP', 'O')
('OR).', 'OR).', 'NNP', 'I-NP', 'O')
A brief overview of these methodologies is presented.
('A', 'A', 'DT', 'B-NP', 'O')
('brief', 'brief', 'JJ', 'I-NP', 'O')
('overview', 'overview', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('methodologies', 'methodology', 'NNS', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('presented.', 'presented.', 'RB', 'B-ADVP', 'O')
We used the Glide program (Friesneref al., 2004) as our docking engine.
('We', 'We', 'PRP', 'B-NP', 'O')
('used', 'use', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Glide', 'Glide', 'NN', 'I-NP', 'B-protein')
('program', 'program', 'NN', 'I-NP', 'I-protein')
('(Friesneref', '(Friesneref', 'NN', 'I-NP', 'I-protein')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2004)', '2004)', 'CD', 'B-NP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('engine.', 'engine.', 'NN', 'I-NP', 'O')
The Glide docking algorithm performs a series of hierarchical searches for locations of possible ligand affinity within the binding site of a receptor.
('The', 'The', 'DT', 'B-NP', 'O')
('Glide', 'Glide', 'NN', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('algorithm', 'algorithm', 'NN', 'I-NP', 'O')
('performs', 'perform', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('series', 'series', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hierarchical', 'hierarchical', 'JJ', 'B-NP', 'O')
('searches', 'search', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('locations', 'location', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('possible', 'possible', 'JJ', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('affinity', 'affinity', 'NN', 'I-NP', 'O')
('within', 'within', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'bind', 'VBG', 'I-NP', 'B-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('receptor.', 'receptor.', 'NN', 'I-NP', 'O')
A rough positioning and scoring algorithm is applied during the initial search step, followed by torsional energy optimization on an OPLA-AA non-bonded potential energy grid for enduring candidate poses.
('A', 'A', 'DT', 'B-NP', 'O')
('rough', 'rough', 'JJ', 'I-NP', 'O')
('positioning', 'positioning', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('algorithm', 'algorithm', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('applied', 'apply', 'VBN', 'I-VP', 'O')
('during', 'during', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('initial', 'initial', 'JJ', 'I-NP', 'O')
('search', 'search', 'NN', 'I-NP', 'O')
('step,', 'step,', 'NN', 'I-NP', 'O')
('followed', 'follow', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('torsional', 'torsional', 'JJ', 'B-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('optimization', 'optimization', 'NN', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('OPLA-AA', 'OPLA-AA', 'NN', 'I-NP', 'O')
('non-bonded', 'non-bonded', 'JJ', 'I-NP', 'O')
('potential', 'potential', 'JJ', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('grid', 'grid', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('enduring', 'endure', 'VBG', 'B-VP', 'O')
('candidate', 'candidate', 'NN', 'B-NP', 'O')
('poses.', 'poses.', 'NNS', 'I-NP', 'O')
The pose conformations of the very best candidates are further refined by using Monte Carlo sampling.
('The', 'The', 'DT', 'B-NP', 'O')
('pose', 'pose', 'JJ', 'I-NP', 'O')
('conformations', 'conformation', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('very', 'very', 'RB', 'I-NP', 'O')
('best', 'good', 'JJS', 'I-NP', 'O')
('candidates', 'candidate', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('further', 'further', 'RBR', 'I-VP', 'O')
('refined', 'refine', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('Monte', 'Monte', 'NNP', 'B-NP', 'O')
('Carlo', 'Carlo', 'NNP', 'I-NP', 'O')
('sampling.', 'sampling.', 'NN', 'I-NP', 'O')
Selection of the final docked pose is accomplished using a Glide score, which is a model energy function that combines empirical and force-field-based terms.
('Selection', 'Selection', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('final', 'final', 'JJ', 'I-NP', 'O')
('docked', 'dock', 'VBN', 'I-NP', 'O')
('pose', 'pose', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('accomplished', 'accomplish', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('Glide', 'Glide', 'NN', 'I-NP', 'B-protein')
('score,', 'score,', 'NN', 'I-NP', 'I-protein')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('combines', 'combine', 'VBZ', 'B-VP', 'O')
('empirical', 'empirical', 'JJ', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('force-field-based', 'force-field-based', 'JJ', 'I-NP', 'O')
('terms.', 'terms.', 'NNS', 'I-NP', 'O')
The Qide score is a modified and extended version of the ChemScore function (Eldridge etal., 1997).
('The', 'The', 'DT', 'B-NP', 'O')
('Qide', 'Qide', 'NNP', 'I-NP', 'O')
('score', 'score', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('modified', 'modify', 'VBN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('extended', 'extend', 'VBN', 'I-NP', 'O')
('version', 'version', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ChemScore', 'ChemScore', 'NNP', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('(Eldridge', '(Eldridge', 'NNP', 'I-NP', 'O')
('etal.,', 'etal.,', 'VBD', 'B-VP', 'O')
('1997).', '1997).', 'CD', 'B-NP', 'O')
The    eMBrAcE    (MacroModel    v9.1)    program    calculates binding energies between ligands and receptors using molecular mechanics energy minimization for docked conformations.
('The', 'The', 'DT', 'B-NP', 'O')
('eMBrAcE', 'eMBrAcE', 'NN', 'I-NP', 'O')
('(MacroModel', '(MacroModel', 'NN', 'I-NP', 'O')
('v9.1)', 'v9.1)', 'NN', 'I-NP', 'O')
('program', 'program', 'NN', 'I-NP', 'O')
('calculates', 'calculate', 'VBZ', 'B-VP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('energies', 'energy', 'NNS', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('ligands', 'ligand', 'NNS', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('receptors', 'receptor', 'NNS', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('molecular', 'molecular', 'JJ', 'B-NP', 'O')
('mechanics', 'mechanic', 'NNS', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('minimization', 'minimization', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('docked', 'dock', 'VBN', 'B-NP', 'O')
('conformations.', 'conformations.', 'NN', 'I-NP', 'O')
eMBrAcE    applies    multiple    minimizations, during which each of the specified pre-positioned ligands is minimized with the receptor.
('eMBrAcE', 'eMBrAcE', 'NN', 'B-NP', 'O')
('applies', 'apply', 'VBZ', 'B-VP', 'O')
('multiple', 'multiple', 'JJ', 'B-NP', 'O')
('minimizations,', 'minimizations,', 'NN', 'I-NP', 'O')
('during', 'during', 'IN', 'B-PP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('specified', 'specify', 'VBN', 'I-NP', 'O')
('pre-positioned', 'pre-positioned', 'JJ', 'I-NP', 'O')
('ligands', 'ligand', 'NNS', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('minimized', 'minimize', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor.', 'receptor.', 'NN', 'I-NP', 'O')
For the energy-minimized structures, the calculation is performed first on the receptor(Eprotein), then on the ligand (En ga nd), and finally on thecomplex (Ecompiex).
('For', 'For', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('energy-minimized', 'energy-minimized', 'JJ', 'I-NP', 'O')
('structures,', 'structures,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('calculation', 'calculation', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('first', 'first', 'RB', 'B-ADVP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('(Eprotein),', '(Eprotein),', 'NN', 'I-NP', 'O')
('then', 'then', 'RB', 'B-ADVP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('(En', '(En', 'NN', 'I-NP', 'O')
('ga', 'ga', 'NN', 'I-NP', 'O')
('nd),', 'nd),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('finally', 'finally', 'RB', 'B-ADVP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('complex', 'complex', 'JJ', 'I-NP', 'O')
('(Ecompiex).', '(Ecompiex).', 'NNP', 'I-NP', 'O')
The energy difference is then calculatedas .
('The', 'The', 'DT', 'B-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('difference', 'difference', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('then', 'then', 'RB', 'I-VP', 'O')
('calculated', 'calculate', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-SBAR', 'O')
('.', '.', '.', 'O', 'O')
This application is used to predict the free binding energybetween a receptor and a ligand.
('This', 'This', 'DT', 'B-NP', 'O')
('application', 'application', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('predict', 'predict', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('ligand.', 'ligand.', 'NN', 'I-NP', 'O')
MM-GBSA is a method that     combines     OPLS     molecular     mechanics     energies (E mm ), surface generalized Born solvation model for polar solvation (C^ gb ), and a nonpolar solvation term (G np ).
('MM-GBSA', 'MM-GBSA', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('combines', 'combine', 'VBZ', 'B-VP', 'O')
('OPLS', 'OPLS', 'NN', 'B-NP', 'O')
('molecular', 'molecular', 'JJ', 'I-NP', 'O')
('mechanics', 'mechanic', 'NNS', 'I-NP', 'O')
('energies', 'energy', 'VBZ', 'B-VP', 'O')
('(E', '(E', 'NN', 'B-NP', 'B-protein')
('mm', 'mm', 'NN', 'I-NP', 'I-protein')
('),', '),', 'VBD', 'B-VP', 'O')
('surface', 'surface', 'NN', 'B-NP', 'O')
('generalized', 'generalize', 'VBN', 'B-VP', 'O')
('Born', 'Born', 'NNP', 'B-NP', 'O')
('solvation', 'solvation', 'NN', 'I-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('polar', 'polar', 'JJ', 'B-NP', 'O')
('solvation', 'solvation', 'NN', 'I-NP', 'O')
('(C^', '(C^', 'NN', 'I-NP', 'B-protein')
('gb', 'gb', 'NN', 'I-NP', 'I-protein')
('),', '),', 'NN', 'I-NP', 'I-protein')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('nonpolar', 'nonpolar', 'JJ', 'I-NP', 'O')
('solvation', 'solvation', 'NN', 'I-NP', 'O')
('term', 'term', 'NN', 'I-NP', 'O')
('(G', '(G', 'NN', 'I-NP', 'O')
('np', 'np', 'NN', 'I-NP', 'O')
(').', ').', '.', 'O', 'O')
The G np term comprises the nonpolar solvent accessible surface area and van der Waals interactions.
('The', 'The', 'DT', 'B-NP', 'O')
('G', 'G', 'NN', 'I-NP', 'O')
('np', 'np', 'NN', 'I-NP', 'O')
('term', 'term', 'NN', 'I-NP', 'O')
('comprises', 'comprise', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nonpolar', 'nonpolar', 'JJ', 'I-NP', 'O')
('solvent', 'solvent', 'NN', 'I-NP', 'O')
('accessible', 'accessible', 'JJ', 'I-NP', 'O')
('surface', 'surface', 'NN', 'I-NP', 'O')
('area', 'area', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('van', 'van', 'NN', 'B-NP', 'O')
('der', 'der', 'NN', 'I-NP', 'O')
('Waals', 'Waal', 'NNS', 'I-NP', 'O')
('interactions.', 'interactions.', 'VBP', 'B-VP', 'O')
The total freeenergy of binding is calculated as .
('The', 'The', 'DT', 'B-NP', 'O')
('total', 'total', 'JJ', 'I-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('calculated', 'calculate', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('.', '.', '.', 'O', 'O')
The Liaison (Liaison v4.0) program is an application for estimating the binding affinities between ligands and receptors, using a linear interaction approximation (LIA) model.
('The', 'The', 'DT', 'B-NP', 'O')
('Liaison', 'Liaison', 'NNP', 'I-NP', 'O')
('(Liaison', '(Liaison', 'NNP', 'I-NP', 'O')
('v4.0)', 'v4.0)', 'NN', 'I-NP', 'O')
('program', 'program', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('application', 'application', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('estimating', 'estimate', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('ligands', 'ligand', 'NNS', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('receptors,', 'receptors,', 'NN', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('linear', 'linear', 'JJ', 'I-NP', 'O')
('interaction', 'interaction', 'NN', 'I-NP', 'O')
('approximation', 'approximation', 'NN', 'I-NP', 'O')
('(LIA)', '(LIA)', 'NN', 'I-NP', 'O')
('model.', 'model.', 'NN', 'I-NP', 'O')
The LIA model is an empirical method fitted to a set of known binding free energies.
('The', 'The', 'DT', 'B-NP', 'O')
('LIA', 'LIA', 'NNP', 'I-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('empirical', 'empirical', 'JJ', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('fitted', 'fit', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('set', 'set', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('known', 'known', 'JJ', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('energies.', 'energies.', 'NN', 'I-NP', 'O')
Liaison runs molecular mechanics (MM) simulations for the ligand-receptor complex, and for the free ligand and free receptor using the surface generalized Born (SGB) continuum solvation model.
('Liaison', 'Liaison', 'NNP', 'B-NP', 'O')
('runs', 'run', 'VBZ', 'B-VP', 'O')
('molecular', 'molecular', 'JJ', 'B-NP', 'O')
('mechanics', 'mechanic', 'NNS', 'I-NP', 'O')
('(MM)', '(MM)', 'NN', 'I-NP', 'O')
('simulations', 'simulation', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand-receptor', 'ligand-receptor', 'NN', 'I-NP', 'O')
('complex,', 'complex,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'B-PP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('free', 'free', 'JJ', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('surface', 'surface', 'NN', 'I-NP', 'O')
('generalized', 'generalize', 'VBN', 'B-VP', 'O')
('Born', 'Born', 'NNP', 'B-NP', 'O')
('(SGB)', '(SGB)', 'NNP', 'I-NP', 'O')
('continuum', 'continuum', 'NN', 'I-NP', 'O')
('solvation', 'solvation', 'NN', 'I-NP', 'O')
('model.', 'model.', 'NN', 'I-NP', 'O')
The simulation data and empirical binding affinities are analyzed to generate the Liaison parameters, which are subsequently used to predict binding energies for other ligands with the same receptor.
('The', 'The', 'DT', 'B-NP', 'O')
('simulation', 'simulation', 'NN', 'I-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('empirical', 'empirical', 'JJ', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('analyzed', 'analyze', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('generate', 'generate', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Liaison', 'Liaison', 'NNP', 'I-NP', 'O')
('parameters,', 'parameters,', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('subsequently', 'subsequently', 'RB', 'I-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('predict', 'predict', 'VB', 'I-VP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('energies', 'energy', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('other', 'other', 'JJ', 'B-NP', 'O')
('ligands', 'ligand', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('same', 'same', 'JJ', 'I-NP', 'O')
('receptor.', 'receptor.', 'NN', 'I-NP', 'O')
The empirical function used by Liaison forthe prediction of binding affinities is as follows.
('The', 'The', 'DT', 'B-NP', 'O')
('empirical', 'empirical', 'JJ', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('used', 'use', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Liaison', 'Liaison', 'NNP', 'B-NP', 'O')
('forthe', 'forthe', 'NNP', 'I-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('as', 'as', 'RB', 'B-ADJP', 'O')
('follows.', 'follows.', 'JJ', 'I-ADJP', 'O')
In this equation, < >, band f represent the ensemble average, the bound form, and the free form of the ligand, respectively.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('equation,', 'equation,', 'NN', 'I-NP', 'O')
('<', '<', 'SYM', 'O', 'O')
('>,', '>,', 'SYM', 'O', 'O')
('band', 'band', 'NN', 'B-NP', 'O')
('f', 'f', 'NN', 'I-NP', 'O')
('represent', 'represent', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ensemble', 'ensemble', 'NN', 'I-NP', 'O')
('average,', 'average,', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('bound', 'bind', 'VBN', 'I-NP', 'O')
('form,', 'form,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('free', 'free', 'JJ', 'I-NP', 'O')
('form', 'form', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand,', 'ligand,', 'NN', 'I-NP', 'O')
('respectively.', 'respectively.', 'NN', 'I-NP', 'O')
Parameters    a,    and    y    are    the    coefficients.
('Parameters', 'Parameter', 'NNS', 'B-NP', 'O')
('a,', 'a,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('y', 'y', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('coefficients.', 'coefficients.', 'NN', 'I-NP', 'O')
Uvdw, Ueiec and Uca, are the van der Waals, electrostatic and cavity energy terms in the SGB model, respectively.
('Uvdw,', 'Uvdw,', 'NNP', 'B-NP', 'O')
('Ueiec', 'Ueiec', 'NNP', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Uca,', 'Uca,', 'NNP', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('van', 'van', 'NN', 'I-NP', 'O')
('der', 'der', 'NN', 'I-NP', 'O')
('Waals,', 'Waals,', 'VBD', 'B-VP', 'O')
('electrostatic', 'electrostatic', 'JJ', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('cavity', 'cavity', 'NN', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('terms', 'term', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('SGB', 'SGB', 'NN', 'I-NP', 'O')
('model,', 'model,', 'NN', 'I-NP', 'O')
('respectively.', 'respectively.', 'NN', 'I-NP', 'O')
The QM-Polarized Ligand Docking (QPLD) protocol is an improved docking method, which incorporates quantum mechanical      and      molecular      mechanical      (QM/MM) calculations (Cho etal., 2005).
('The', 'The', 'DT', 'B-NP', 'O')
('QM-Polarized', 'QM-Polarized', 'JJ', 'I-NP', 'O')
('Ligand', 'Ligand', 'NN', 'I-NP', 'O')
('Docking', 'Dock', 'VBG', 'B-VP', 'O')
('(QPLD)', '(QPLD)', 'NN', 'B-NP', 'O')
('protocol', 'protocol', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('improved', 'improve', 'VBN', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('method,', 'method,', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('incorporates', 'incorporate', 'VBZ', 'B-VP', 'O')
('quantum', 'quantum', 'NN', 'B-NP', 'O')
('mechanical', 'mechanical', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('molecular', 'molecular', 'JJ', 'I-NP', 'O')
('mechanical', 'mechanical', 'JJ', 'I-NP', 'O')
('(QM/MM)', '(QM/MM)', 'NN', 'I-NP', 'O')
('calculations', 'calculation', 'NNS', 'I-NP', 'O')
('(Cho', '(Cho', 'VBP', 'B-VP', 'O')
('etal.,', 'etal.,', 'NN', 'B-NP', 'O')
('2005).', '2005).', 'CD', 'I-NP', 'O')
This method applies the Glide algorithm to generate the best candidate poses for ligand docking.
('This', 'This', 'DT', 'B-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('applies', 'apply', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Glide', 'Glide', 'NN', 'I-NP', 'O')
('algorithm', 'algorithm', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('generate', 'generate', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('best', 'good', 'JJS', 'I-NP', 'O')
('candidate', 'candidate', 'NN', 'I-NP', 'O')
('poses', 'pose', 'VBZ', 'B-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ligand', 'ligand', 'NN', 'B-NP', 'O')
('docking.', 'docking.', 'NN', 'I-NP', 'O')
The partial charges on the atoms of the ligand are then replaced with charges derived from QM calculations on the ligand in the field of the receptor for each ligand-receptor complex.
('The', 'The', 'DT', 'B-NP', 'O')
('partial', 'partial', 'JJ', 'I-NP', 'O')
('charges', 'charge', 'NNS', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('atoms', 'atom', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('then', 'then', 'RB', 'I-VP', 'O')
('replaced', 'replace', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('charges', 'charge', 'NNS', 'B-NP', 'O')
('derived', 'derive', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('QM', 'QM', 'NN', 'B-NP', 'O')
('calculations', 'calculation', 'NNS', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('field', 'field', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('ligand-receptor', 'ligand-receptor', 'NN', 'I-NP', 'O')
('complex.', 'complex.', 'NN', 'I-NP', 'O')
The charges are calculated from the electrostatic potential energy surface of the ligand, which is generated from a single-point calculation using the BLYP density function forthe QM region.
('The', 'The', 'DT', 'B-NP', 'O')
('charges', 'charge', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('calculated', 'calculate', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('electrostatic', 'electrostatic', 'JJ', 'I-NP', 'O')
('potential', 'potential', 'JJ', 'I-NP', 'O')
('energy', 'energy', 'NN', 'I-NP', 'O')
('surface', 'surface', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand,', 'ligand,', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('generated', 'generate', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('single-point', 'single-point', 'JJ', 'I-NP', 'O')
('calculation', 'calculation', 'NN', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('BLYP', 'BLYP', 'NN', 'I-NP', 'O')
('density', 'density', 'NN', 'I-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('forthe', 'forthe', 'VBP', 'B-VP', 'O')
('QM', 'QM', 'NN', 'B-NP', 'O')
('region.', 'region.', 'NN', 'I-NP', 'O')
Glide then re-docks each of the ligands with updated atom charges,and returns the most energetically favorable pose.
('Glide', 'Glide', 'NN', 'B-NP', 'O')
('then', 'then', 'RB', 'B-ADVP', 'O')
('re-docks', 're-dock', 'VBZ', 'B-VP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligands', 'ligand', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('updated', 'update', 'VBN', 'B-NP', 'O')
('atom', 'atom', 'NN', 'I-NP', 'O')
('charges,', 'charges,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('returns', 'return', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('most', 'most', 'RBS', 'I-NP', 'O')
('energetically', 'energetically', 'RB', 'I-NP', 'O')
('favorable', 'favorable', 'JJ', 'I-NP', 'O')
('pose.', 'pose.', 'NN', 'I-NP', 'O')
Two receptor co-cry st al structures, estrogen receptor a (ERa,    PDB    entry:    3ERD)    and    peroxisome    proliferator- activated receptor y (P PA Ry, PDB entry: 1KNU), both of which belong to the nuclear receptor superfamily, were used in this study.
('Two', 'Two', 'CD', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('co-cry', 'co-cry', 'NN', 'I-NP', 'O')
('st', 'st', 'NN', 'I-NP', 'O')
('al', 'al', 'JJ', 'I-NP', 'O')
('structures,', 'structures,', 'NN', 'I-NP', 'O')
('estrogen', 'estrogen', 'NN', 'I-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('(ERa,', '(ERa,', 'NN', 'I-NP', 'B-protein')
('PDB', 'PDB', 'NN', 'I-NP', 'I-protein')
('entry:', 'entry:', 'NN', 'I-NP', 'O')
('3ERD)', '3ERD)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('peroxisome', 'peroxisome', 'NN', 'B-NP', 'B-protein')
('proliferator-', 'proliferator-', 'NN', 'I-NP', 'I-protein')
('activated', 'activate', 'VBD', 'B-VP', 'I-protein')
('receptor', 'receptor', 'NN', 'B-NP', 'I-protein')
('y', 'y', 'NN', 'I-NP', 'I-protein')
('(P', '(P', 'NNP', 'I-NP', 'I-protein')
('PA', 'PA', 'NNP', 'I-NP', 'I-protein')
('Ry,', 'Ry,', 'NNP', 'I-NP', 'I-protein')
('PDB', 'PDB', 'NNP', 'I-NP', 'I-protein')
('entry:', 'entry:', ':', 'O', 'I-protein')
('1KNU),', '1KNU),', 'IN', 'B-PP', 'O')
('both', 'both', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('belong', 'belong', 'VBP', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nuclear', 'nuclear', 'JJ', 'I-NP', 'B-protein')
('receptor', 'receptor', 'NN', 'I-NP', 'I-protein')
('superfamily,', 'superfamily,', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study.', 'study.', 'NN', 'I-NP', 'O')
The coordinates for these proteins were obtained from the RCSB Protein Data Bank (http://www.
('The', 'The', 'DT', 'B-NP', 'O')
('coordinates', 'coordinate', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('proteins', 'protein', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('obtained', 'obtain', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RCSB', 'RCSB', 'NNP', 'I-NP', 'O')
('Protein', 'Protein', 'NNP', 'I-NP', 'O')
('Data', 'Data', 'NNP', 'I-NP', 'O')
('Bank', 'Bank', 'NNP', 'I-NP', 'O')
('(http://www.', '(http://www.', 'NNP', 'I-NP', 'O')
rcsb.org/pdb ).
('rcsb.org/pdb', 'rcsb.org/pdb', 'NN', 'B-NP', 'O')
(').', ').', 'NN', 'I-NP', 'O')
We    obtained    the    SMILES    representation    of    232    test compounds, for which the experimental binding affinities were taken from published data (Blair et al., 2000; Hong et al., 2002).
('We', 'We', 'PRP', 'B-NP', 'O')
('obtained', 'obtain', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('SMILES', 'SMILES', 'NNP', 'I-NP', 'O')
('representation', 'representation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('232', '232', 'CD', 'B-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('compounds,', 'compounds,', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('experimental', 'experimental', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('taken', 'take', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('published', 'publish', 'VBN', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('(Blair', '(Blair', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2000;', '2000;', ':', 'O', 'O')
('Hong', 'Hong', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2002).', '2002).', 'CD', 'B-NP', 'O')
The experimental binding affinities were represented as log(RBA) (Yoon and Welsh, 2004), where RBA refers to the relative binding affinity and log(RBA) is defined as the logarithm of the percent ratio of the IC50 between 17/?-estradiol and a test compound.
('The', 'The', 'DT', 'B-NP', 'O')
('experimental', 'experimental', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('represented', 'represent', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('(Yoon', '(Yoon', 'NNP', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Welsh,', 'Welsh,', 'NNP', 'B-NP', 'O')
('2004),', '2004),', 'CD', 'I-NP', 'O')
('where', 'where', 'WRB', 'B-ADVP', 'O')
('RBA', 'RBA', 'NN', 'B-NP', 'B-protein')
('refers', 'refer', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('relative', 'relative', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinity', 'affinity', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('defined', 'define', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('logarithm', 'logarithm', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('percent', 'percent', 'NN', 'I-NP', 'O')
('ratio', 'ratio', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('IC50', 'IC50', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('17/?-estradiol', '17/?-estradiol', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('compound.', 'compound.', 'NN', 'I-NP', 'O')
Thus, theRBAof 1estradiol is 100, and log(RBA) of 17/3-estradiol is 2.
('Thus,', 'Thus,', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RBAof', 'RBAof', 'NN', 'I-NP', 'O')
('1estradiol', '1estradiol', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('100,', '100,', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('17/3-estradiol', '17/3-estradiol', 'NN', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('2.', '2.', 'CD', 'B-NP', 'O')
We then generated 3D energy-minimized conformations of these compounds using the LigPrep program (LigPrep V2.0, Schrodinger, LLC: Portland, OR.).
('We', 'We', 'PRP', 'B-NP', 'O')
('then', 'then', 'RB', 'B-ADVP', 'O')
('generated', 'generate', 'VBD', 'B-VP', 'O')
('3D', '3D', 'NN', 'B-NP', 'O')
('energy-minimized', 'energy-minimized', 'JJ', 'I-NP', 'O')
('conformations', 'conformation', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('LigPrep', 'LigPrep', 'NN', 'I-NP', 'O')
('program', 'program', 'NN', 'I-NP', 'O')
('(LigPrep', '(LigPrep', 'NNP', 'I-NP', 'O')
('V2.0,', 'V2.0,', 'NNP', 'I-NP', 'O')
('Schrodinger,', 'Schrodinger,', 'NNP', 'I-NP', 'O')
('LLC:', 'LLC:', 'NNP', 'I-NP', 'O')
('Portland,', 'Portland,', 'NNP', 'I-NP', 'O')
('OR.).', 'OR.).', 'NNP', 'I-NP', 'O')
Compounds with atom types that were not recognized by LigPrep were eliminated from the test set.
('Compounds', 'Compound', 'NNS', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('atom', 'atom', 'NN', 'B-NP', 'O')
('types', 'type', 'NNS', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('recognized', 'recognize', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('LigPrep', 'LigPrep', 'NN', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('eliminated', 'eliminate', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('set.', 'set.', 'NN', 'I-NP', 'O')
This resulted in the retention of 173 of the original 232 compounds.
('This', 'This', 'DT', 'B-NP', 'O')
('resulted', 'result', 'VBD', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('retention', 'retention', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('173', '173', 'CD', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('original', 'original', 'JJ', 'I-NP', 'O')
('232', '232', 'CD', 'I-NP', 'O')
('compounds.', 'compounds.', 'NNS', 'I-NP', 'O')
For Glide docking, PDB co-crystal structures of ERa and PPARy were prepared using the Maestro interface of the Sch ro dinger software package.All wat ermoleculeswere removed, and multi meric complexes were simplified from the PDB structures.
('For', 'For', 'IN', 'B-PP', 'O')
('Glide', 'Glide', 'NN', 'B-NP', 'B-protein')
('docking,', 'docking,', 'NN', 'I-NP', 'I-protein')
('PDB', 'PDB', 'NN', 'I-NP', 'I-protein')
('co-crystal', 'co-crystal', 'JJ', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('ERa', 'ERa', 'NN', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('PPARy', 'PPARy', 'NN', 'I-NP', 'B-protein')
('were', 'be', 'VBD', 'B-VP', 'O')
('prepared', 'prepare', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Maestro', 'Maestro', 'NNP', 'I-NP', 'O')
('interface', 'interface', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Sch', 'Sch', 'NNP', 'I-NP', 'O')
('ro', 'ro', 'NN', 'I-NP', 'O')
('dinger', 'dinger', 'NN', 'I-NP', 'O')
('software', 'software', 'NN', 'I-NP', 'O')
('package.All', 'package.All', 'NN', 'I-NP', 'O')
('wat', 'wat', 'NN', 'I-NP', 'O')
('ermoleculeswere', 'ermoleculeswere', 'VBD', 'B-VP', 'O')
('removed,', 'removed,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('multi', 'multi', 'JJ', 'B-NP', 'B-protein')
('meric', 'meric', 'JJ', 'I-NP', 'I-protein')
('complexes', 'complex', 'NNS', 'I-NP', 'I-protein')
('were', 'be', 'VBD', 'B-VP', 'O')
('simplified', 'simplify', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('PDB', 'PDB', 'NN', 'I-NP', 'O')
('structures.', 'structures.', 'NN', 'I-NP', 'O')
Prior to molecular docking, receptor structures    were    preprocessed    using    protein    preparation and refinement components in the Qide docking package.
('Prior', 'Prior', 'RB', 'B-ADVP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('molecular', 'molecular', 'JJ', 'B-NP', 'O')
('docking,', 'docking,', 'NN', 'I-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('preprocessed', 'preprocesse', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('protein', 'protein', 'NN', 'B-NP', 'O')
('preparation', 'preparation', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('refinement', 'refinement', 'NN', 'B-NP', 'O')
('components', 'component', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Qide', 'Qide', 'NNP', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('package.', 'package.', 'NN', 'I-NP', 'O')
Hydrogen atoms were added by applying an all-atom force field.
('Hydrogen', 'Hydrogen', 'NN', 'B-NP', 'O')
('atoms', 'atom', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('added', 'add', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('applying', 'apply', 'VBG', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('all-atom', 'all-atom', 'JJ', 'I-NP', 'O')
('force', 'force', 'NN', 'I-NP', 'O')
('field.', 'field.', 'NN', 'I-NP', 'O')
Side chains that were not closetothe ligand binding site and did not participate in salt bridges were neutralized.
('Side', 'Side', 'NN', 'B-NP', 'B-protein')
('chains', 'chain', 'NNS', 'I-NP', 'I-protein')
('that', 'that', 'WDT', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('closetothe', 'closetothe', 'VB', 'I-VP', 'O')
('ligand', 'ligand', 'NN', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('site', 'site', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('did', 'do', 'VBD', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('participate', 'participate', 'VB', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('salt', 'salt', 'NN', 'B-NP', 'O')
('bridges', 'bridge', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('neutralized.', 'neutralized.', 'RB', 'B-ADVP', 'O')
A restrained minimization using the OPLS-AA force field was performed to refine the complex structure.
('A', 'A', 'DT', 'B-NP', 'O')
('restrained', 'restrained', 'JJ', 'I-NP', 'O')
('minimization', 'minimization', 'NN', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('OPLS-AA', 'OPLS-AA', 'NN', 'I-NP', 'O')
('force', 'force', 'NN', 'I-NP', 'O')
('field', 'field', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('refine', 'refine', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('complex', 'complex', 'NN', 'I-NP', 'O')
('structure.', 'structure.', 'NN', 'I-NP', 'O')
This procedure     reorients     side-chain hydroxyl groups, and alleviates     potential     steric clashes.
('This', 'This', 'DT', 'B-NP', 'O')
('procedure', 'procedure', 'NN', 'I-NP', 'O')
('reorients', 'reorient', 'NNS', 'I-NP', 'O')
('side-chain', 'side-chain', 'JJ', 'B-NP', 'O')
('hydroxyl', 'hydroxyl', 'NN', 'I-NP', 'O')
('groups,', 'groups,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('alleviates', 'alleviate', 'VBZ', 'B-VP', 'O')
('potential', 'potential', 'JJ', 'B-NP', 'O')
('steric', 'steric', 'JJ', 'I-NP', 'O')
('clashes.', 'clashes.', 'NNS', 'I-NP', 'O')
The minimization process was continued until the average RMS deviation of the non-hydrogen atoms reached the specified limit of 0.3 A. Oice receptor grid files had been generated, all compounds were docked to the receptor structures usingthe standard mode of Qide docking (Glide SP 4.0).
('The', 'The', 'DT', 'B-NP', 'O')
('minimization', 'minimization', 'NN', 'I-NP', 'O')
('process', 'process', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('continued', 'continue', 'VBN', 'I-VP', 'O')
('until', 'until', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('average', 'average', 'JJ', 'I-NP', 'O')
('RMS', 'RMS', 'NN', 'I-NP', 'O')
('deviation', 'deviation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('non-hydrogen', 'non-hydrogen', 'JJ', 'I-NP', 'O')
('atoms', 'atom', 'NNS', 'I-NP', 'O')
('reached', 'reach', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('specified', 'specify', 'VBN', 'I-NP', 'O')
('limit', 'limit', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('0.3', '0.3', 'CD', 'B-NP', 'O')
('A.', 'A.', 'NN', 'I-NP', 'O')
('Oice', 'Oice', 'NNP', 'I-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('grid', 'grid', 'NN', 'I-NP', 'O')
('files', 'file', 'NNS', 'I-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('generated,', 'generated,', 'IN', 'B-PP', 'O')
('all', 'all', 'DT', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('docked', 'dock', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('mode', 'mode', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Qide', 'Qide', 'NN', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('(Glide', '(Glide', 'NN', 'I-NP', 'O')
('SP', 'SP', 'NN', 'I-NP', 'O')
('4.0).', '4.0).', 'CD', 'I-NP', 'O')
TheeMBrAcE,    Prime    MM-GBSAand    Liaison    calculations were    performed    using    the    Ligand    &    Structure-Based Descriptors (LSBD) application of the Schrodinger software package.
('TheeMBrAcE,', 'TheeMBrAcE,', 'NNP', 'B-NP', 'O')
('Prime', 'Prime', 'NNP', 'I-NP', 'O')
('MM-GBSAand', 'MM-GBSAand', 'NNP', 'I-NP', 'O')
('Liaison', 'Liaison', 'NNP', 'I-NP', 'O')
('calculations', 'calculation', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Ligand', 'Ligand', 'NNP', 'I-NP', 'O')
('&', '&', 'CC', 'I-NP', 'O')
('Structure-Based', 'Structure-Based', 'JJ', 'I-NP', 'O')
('Descriptors', 'Descriptor', 'NNS', 'I-NP', 'O')
('(LSBD)', '(LSBD)', 'NN', 'I-NP', 'O')
('application', 'application', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Schrodinger', 'Schrodinger', 'NNP', 'I-NP', 'O')
('software', 'software', 'NN', 'I-NP', 'O')
('package.', 'package.', 'NN', 'I-NP', 'O')
These calculations were applied the ligand-receptor complex structures obtained from Glide docking.
('These', 'These', 'DT', 'B-NP', 'O')
('calculations', 'calculation', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('applied', 'apply', 'VBN', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand-receptor', 'ligand-receptor', 'JJ', 'I-NP', 'O')
('complex', 'complex', 'JJ', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('obtained', 'obtain', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('Glide', 'Glide', 'NN', 'B-NP', 'O')
('docking.', 'docking.', 'NN', 'I-NP', 'O')
The grid for QPLDwas set up as a grid file in PPARy using the grid generation data from the previous Glide standard docking operation.
('The', 'The', 'DT', 'B-NP', 'O')
('grid', 'grid', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('QPLDwas', 'QPLDwas', 'NNP', 'B-NP', 'O')
('set', 'set', 'VBD', 'B-VP', 'O')
('up', 'up', 'RP', 'B-PRT', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('grid', 'grid', 'JJ', 'I-NP', 'O')
('file', 'file', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('PPARy', 'PPARy', 'NN', 'B-NP', 'B-protein')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('grid', 'grid', 'JJ', 'I-NP', 'O')
('generation', 'generation', 'NN', 'I-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('Glide', 'Glide', 'NN', 'I-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('operation.', 'operation.', 'NN', 'I-NP', 'O')
The ligand to be QPLD-docked was prepared from the cognate ligand bound in PPARy.
('The', 'The', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('QPLD-docked', 'QPLD-docked', 'JJ', 'B-ADJP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('prepared', 'prepare', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cognate', 'cognate', 'JJ', 'I-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('bound', 'bind', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('PPARy.', 'PPARy.', 'NNP', 'B-NP', 'O')
An energy-minimized conformation of the extracted cognateligand    was    generated    using    LigPrep.
('An', 'An', 'DT', 'B-NP', 'O')
('energy-minimized', 'energy-minimized', 'JJ', 'I-NP', 'O')
('conformation', 'conformation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('extracted', 'extract', 'VBN', 'I-NP', 'O')
('cognate', 'cognate', 'JJ', 'I-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('generated', 'generate', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('LigPrep.', 'LigPrep.', 'NNP', 'B-NP', 'O')
The    level    of quantum-mechanical treatment was set up as Fast mode.
('The', 'The', 'DT', 'B-NP', 'O')
('level', 'level', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('quantum-mechanical', 'quantum-mechanical', 'JJ', 'B-NP', 'O')
('treatment', 'treatment', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('set', 'set', 'VBN', 'I-VP', 'O')
('up', 'up', 'RP', 'B-PRT', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('Fast', 'Fast', 'NN', 'B-NP', 'O')
('mode.', 'mode.', 'NN', 'I-NP', 'O')
One    of    the    key    challenges    in    computer-aided    drug discovery is to maximize the capabilities of the method in use for predicting and rank-ordering the binding affinities of compounds for a given target protein.
('One', 'One', 'CD', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('key', 'key', 'JJ', 'I-NP', 'O')
('challenges', 'challenge', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('computer-aided', 'computer-aided', 'JJ', 'B-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('maximize', 'maximize', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('capabilities', 'capability', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('use', 'use', 'NN', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('predicting', 'predict', 'VBG', 'B-VP', 'O')
('and', 'and', 'CC', 'I-VP', 'O')
('rank-ordering', 'rank-ordere', 'VBG', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities', 'affinity', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('compounds', 'compound', 'NNS', 'B-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('given', 'give', 'VBN', 'I-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('protein.', 'protein.', 'NN', 'I-NP', 'O')
The efficiency of a prediction method is predominantly determined by these capabilities.
('The', 'The', 'DT', 'B-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('predominantly', 'predominantly', 'RB', 'I-VP', 'O')
('determined', 'determine', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('capabilities.', 'capabilities.', 'NNS', 'I-NP', 'O')
Various descriptors extracted from the structural information on ligand-receptor complex may provide an advantageous solution to creating a reliable binding-affinity-prediction model.
('Various', 'Various', 'JJ', 'B-NP', 'O')
('descriptors', 'descriptor', 'NNS', 'I-NP', 'O')
('extracted', 'extract', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('structural', 'structural', 'JJ', 'I-NP', 'O')
('information', 'information', 'NN', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('ligand-receptor', 'ligand-receptor', 'NN', 'B-NP', 'B-protein')
('complex', 'complex', 'NN', 'I-NP', 'I-protein')
('may', 'may', 'MD', 'B-VP', 'O')
('provide', 'provide', 'VB', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('advantageous', 'advantageous', 'JJ', 'I-NP', 'O')
('solution', 'solution', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('creating', 'create', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('reliable', 'reliable', 'JJ', 'I-NP', 'O')
('binding-affinity-prediction', 'binding-affinity-prediction', 'NN', 'I-NP', 'O')
('model.', 'model.', 'NN', 'I-NP', 'O')
Here, we combined the results obtained from a standard docking protocol with data from three different structure-based descriptors, and then investigated the utility of these descriptors on the virtual screening efficiency for ERa ligands (Fig.
('Here,', 'Here,', 'RB', 'B-ADVP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('combined', 'combine', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('obtained', 'obtain', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('protocol', 'protocol', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('data', 'datum', 'NNS', 'B-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('three', 'three', 'CD', 'B-NP', 'O')
('different', 'different', 'JJ', 'I-NP', 'O')
('structure-based', 'structure-based', 'JJ', 'I-NP', 'O')
('descriptors,', 'descriptors,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('then', 'then', 'RB', 'B-VP', 'O')
('investigated', 'investigate', 'VBD', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('utility', 'utility', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('descriptors', 'descriptor', 'NNS', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ERa', 'ERa', 'NN', 'B-NP', 'B-protein')
('ligands', 'ligand', 'NNS', 'I-NP', 'I-protein')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
1).
('1).', '1).', 'LS', 'B-LST', 'O')
The virtual screening efficiency was compared using an analysis of receiver operating characteristic (ROC) curves (Hand ef a/., 2001).
('The', 'The', 'DT', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('compared', 'compare', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('receiver', 'receiver', 'NN', 'B-NP', 'O')
('operating', 'operate', 'VBG', 'B-VP', 'O')
('characteristic', 'characteristic', 'JJ', 'B-NP', 'O')
('(ROC)', '(ROC)', 'NN', 'I-NP', 'B-protein')
('curves', 'curve', 'VBZ', 'B-VP', 'O')
('(Hand', '(Hand', 'NN', 'B-NP', 'B-protein')
('ef', 'ef', 'NN', 'I-NP', 'I-protein')
('a/.,', 'a/.,', 'IN', 'B-PP', 'O')
('2001).', '2001).', 'CD', 'B-NP', 'O')
A ROC curve describes the tradeoff between    sensitivity    and    specificity,    where    the    sensitivity is defined as the ability of the model to avoid false negatives, and the specificity relates to its ability to avoid false positives.
('A', 'A', 'DT', 'B-NP', 'O')
('ROC', 'ROC', 'NN', 'I-NP', 'O')
('curve', 'curve', 'NN', 'I-NP', 'O')
('describes', 'describe', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('tradeoff', 'tradeoff', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('sensitivity', 'sensitivity', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('specificity,', 'specificity,', 'NN', 'I-NP', 'O')
('where', 'where', 'WRB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sensitivity', 'sensitivity', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('defined', 'define', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ability', 'ability', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('avoid', 'avoid', 'VB', 'I-VP', 'O')
('false', 'false', 'JJ', 'B-NP', 'O')
('negatives,', 'negatives,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('specificity', 'specificity', 'NN', 'I-NP', 'O')
('relates', 'relate', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('ability', 'ability', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('avoid', 'avoid', 'VB', 'I-VP', 'O')
('false', 'false', 'JJ', 'B-NP', 'O')
('positives.', 'positives.', 'NNS', 'I-NP', 'O')
The area underthe ROC curve (AUC) is a measure of the test accuracy.
('The', 'The', 'DT', 'B-NP', 'O')
('area', 'area', 'NN', 'I-NP', 'O')
('underthe', 'underthe', 'NN', 'I-NP', 'O')
('ROC', 'ROC', 'NN', 'I-NP', 'O')
('curve', 'curve', 'NN', 'I-NP', 'O')
('(AUC)', '(AUC)', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('measure', 'measure', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('accuracy.', 'accuracy.', 'NN', 'I-NP', 'O')
For example, an AUC value of 0.5 represents a random    prediction,    whereas    1.0 represents a perfect prediction.
('For', 'For', 'IN', 'B-PP', 'O')
('example,', 'example,', 'NN', 'B-NP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('AUC', 'AUC', 'NN', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('0.5', '0.5', 'CD', 'B-NP', 'O')
('represents', 'represent', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-protein')
('prediction,', 'prediction,', 'NN', 'I-NP', 'I-protein')
('whereas', 'whereas', 'IN', 'B-PP', 'I-protein')
('1.0', '1.0', 'CD', 'B-NP', 'I-protein')
('represents', 'represent', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('perfect', 'perfect', 'JJ', 'I-NP', 'O')
('prediction.', 'prediction.', 'NN', 'I-NP', 'O')
For a total of 94 true positives with log(RBA) > -4.0 (corresponding to > 200 pM activity), AUC values ranged narrowly from 0.71 to 0.75, depending on the scoring methods    tested.
('For', 'For', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('total', 'total', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('94', '94', 'CD', 'B-NP', 'O')
('true', 'true', 'JJ', 'I-NP', 'O')
('positives', 'positive', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('>', '>', 'SYM', 'O', 'O')
('-4.0', '-4.0', 'CD', 'B-NP', 'O')
('(corresponding', '(corresponde', 'VBG', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('>', '>', 'JJR', 'B-NP', 'O')
('200', '200', 'CD', 'I-NP', 'O')
('pM', 'pM', 'NN', 'I-NP', 'O')
('activity),', 'activity),', 'NN', 'I-NP', 'O')
('AUC', 'AUC', 'NN', 'I-NP', 'O')
('values', 'value', 'NNS', 'I-NP', 'O')
('ranged', 'range', 'VBD', 'B-VP', 'O')
('narrowly', 'narrowly', 'RB', 'B-ADVP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('0.71', '0.71', 'CD', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('0.75,', '0.75,', 'CD', 'B-NP', 'O')
('depending', 'depend', 'VBG', 'B-PP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('scoring', 'score', 'VBG', 'I-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('tested.', 'tested.', 'NN', 'I-NP', 'O')
The    standard    docking    scoring    (Glide score in the figure) method having 0.75 AUC could slightly enrich the virtual screening, and was better than the otherdescriptor-combined scoring methods (Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('scoring', 'score', 'VBG', 'B-VP', 'O')
('(Glide', '(Glide', 'NN', 'B-NP', 'O')
('score', 'score', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('figure)', 'figure)', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('having', 'have', 'VBG', 'B-VP', 'O')
('0.75', '0.75', 'CD', 'B-NP', 'O')
('AUC', 'AUC', 'NN', 'I-NP', 'O')
('could', 'could', 'MD', 'B-VP', 'O')
('slightly', 'slightly', 'RB', 'I-VP', 'O')
('enrich', 'enrich', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening,', 'screening,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('better', 'good', 'JJR', 'B-ADJP', 'O')
('than', 'than', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('other', 'other', 'JJ', 'I-NP', 'O')
('descriptor-combined', 'descriptor-combined', 'JJ', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
1a).
('1a).', '1a).', 'LS', 'B-LST', 'O')
In Figure 1b we applied a more stringent definition of “active” versus “inactive” compounds.
('In', 'In', 'IN', 'B-PP', 'O')
('Figure', 'Figure', 'NN', 'B-NP', 'O')
('1b', '1b', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('applied', 'apply', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('more', 'more', 'RBR', 'I-NP', 'O')
('stringent', 'stringent', 'JJ', 'I-NP', 'O')
('definition', 'definition', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('“active”', '“active”', 'NN', 'B-NP', 'O')
('versus', 'versus', 'IN', 'B-PP', 'O')
('“inactive”', '“inactive”', 'NN', 'B-NP', 'O')
('compounds.', 'compounds.', 'NNS', 'I-NP', 'O')
Since ~10 p,M activity is generally the minimum required to identify initial lead compounds in drug discovery programs, we set log(RBA) > -2 as thecutoff, which corresponds to a 10-100 ( ll M activity for ERa.
('Since', 'Since', 'IN', 'B-SBAR', 'O')
('~10', '~10', 'CD', 'B-NP', 'O')
('p,M', 'p,M', 'NN', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('generally', 'generally', 'RB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('minimum', 'minimum', 'NN', 'I-NP', 'O')
('required', 'require', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('initial', 'initial', 'JJ', 'B-NP', 'O')
('lead', 'lead', 'JJ', 'I-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('drug', 'drug', 'NN', 'B-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('programs,', 'programs,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('set', 'set', 'VBP', 'B-VP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('>', '>', 'SYM', 'B-NP', 'O')
('-2', '-2', 'CD', 'B-NP', 'O')
('as', 'as', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cutoff,', 'cutoff,', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('corresponds', 'correspond', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('10-100', '10-100', 'CD', 'I-NP', 'O')
('(', '(', '(', 'O', 'O')
('ll', 'll', 'NN', 'B-NP', 'O')
('M', 'M', 'NN', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ERa.', 'ERa.', 'NN', 'B-NP', 'B-protein')
In this case the Liaison scoring method (LiaScore in the figure) significantly improved the efficiency of virtual screening.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('case', 'case', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Liaison', 'Liaison', 'NNP', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('(LiaScore', '(LiaScore', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('figure)', 'figure)', 'NN', 'I-NP', 'O')
('significantly', 'significantly', 'RB', 'B-ADVP', 'O')
('improved', 'improve', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('virtual', 'virtual', 'JJ', 'B-NP', 'O')
('screening.', 'screening.', 'NN', 'I-NP', 'O')
On the other hand the Prime MM-GBSA method (MM-GBSA    in    Figure)    showed    the    lowest    level    of enrichment    of    the    process.
('On', 'On', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('other', 'other', 'JJ', 'I-NP', 'O')
('hand', 'hand', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Prime', 'Prime', 'NNP', 'I-NP', 'O')
('MM-GBSA', 'MM-GBSA', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('(MM-GBSA', '(MM-GBSA', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Figure)', 'Figure)', 'NN', 'B-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('lowest', 'low', 'JJS', 'I-NP', 'O')
('level', 'level', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('enrichment', 'enrichment', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('process.', 'process.', 'NN', 'I-NP', 'O')
An    even    more    stringent definition of log(RBA) > 0, corresponding to the binding affinity in a nanomolar activity range, can indicate a lead compound as being ‘promising’ in general drug discovery terms.
('An', 'An', 'DT', 'B-NP', 'O')
('even', 'even', 'RB', 'I-NP', 'O')
('more', 'more', 'RBR', 'I-NP', 'O')
('stringent', 'stringent', 'JJ', 'I-NP', 'O')
('definition', 'definition', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('>', '>', 'SYM', 'O', 'O')
('0,', '0,', 'CD', 'B-NP', 'O')
('corresponding', 'correspond', 'VBG', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinity', 'affinity', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('nanomolar', 'nanomolar', 'JJ', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('range,', 'range,', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('indicate', 'indicate', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('lead', 'lead', 'NN', 'I-NP', 'O')
('compound', 'compound', 'NN', 'I-NP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('being', 'be', 'VBG', 'B-VP', 'O')
('‘promising’', '‘promising’', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('general', 'general', 'JJ', 'B-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('terms.', 'terms.', 'NN', 'I-NP', 'O')
At this cutoff value only 13 compounds were classified as active.
('At', 'At', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('cutoff', 'cutoff', 'NN', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('only', 'only', 'RB', 'B-NP', 'O')
('13', '13', 'CD', 'I-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('classified', 'classify', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('active.', 'active.', 'NN', 'B-NP', 'O')
The overall trends in the graphs were similar to the graphs of log(RBA) > -2 cutoff.
('The', 'The', 'DT', 'B-NP', 'O')
('overall', 'overall', 'JJ', 'I-NP', 'O')
('trends', 'trend', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('graphs', 'graph', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('similar', 'similar', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('graphs', 'graph', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('log(RBA)', 'log(RBA)', 'NN', 'B-NP', 'O')
('>', '>', 'SYM', 'O', 'O')
('-2', '-2', 'CD', 'B-NP', 'O')
('cutoff.', 'cutoff.', 'NN', 'I-NP', 'O')
The virtualscreening efficiency was generally improved, except in the case of the MM-GBSA scoring method (Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('generally', 'generally', 'RB', 'I-VP', 'O')
('improved,', 'improved,', 'VB', 'I-VP', 'O')
('except', 'except', 'IN', 'B-PP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('case', 'case', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('MM-GBSA', 'MM-GBSA', 'NN', 'I-NP', 'O')
('scoring', 'scoring', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NN', 'I-NP', 'O')
1c).
('1c).', '1c).', 'LS', 'B-LST', 'O')
These results indicate that methodologies with a better prediction precision in binding affinities, though more time-consuming, can provide a significant advantage in prioritizing candidate compounds with high biological activity (low micromolar or nanomolar activity).
('These', 'These', 'DT', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('indicate', 'indicate', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('methodologies', 'methodology', 'NNS', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('better', 'good', 'JJR', 'I-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('precision', 'precision', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('affinities,', 'affinities,', 'NN', 'I-NP', 'O')
('though', 'though', 'IN', 'B-SBAR', 'O')
('more', 'more', 'JJR', 'B-NP', 'O')
('time-consuming,', 'time-consuming,', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('provide', 'provide', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('advantage', 'advantage', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('prioritizing', 'prioritize', 'VBG', 'B-VP', 'O')
('candidate', 'candidate', 'NN', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('high', 'high', 'JJ', 'B-NP', 'O')
('biological', 'biological', 'JJ', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('(low', '(low', 'VBP', 'B-VP', 'O')
('micromolar', 'micromolar', 'JJ', 'B-NP', 'O')
('or', 'or', 'CC', 'I-NP', 'O')
('nanomolar', 'nanomolar', 'JJ', 'I-NP', 'O')
('activity).', 'activity).', 'NN', 'I-NP', 'O')
Among the scoring methods tested, the Prime MM-GBSA method showed a relatively poor prediction capability when screening the compounds with high binding affinities.
('Among', 'Among', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('scoring', 'score', 'VBG', 'I-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('tested,', 'tested,', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Prime', 'Prime', 'JJ', 'I-NP', 'O')
('MM-GBSA', 'MM-GBSA', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('relatively', 'relatively', 'RB', 'I-NP', 'O')
('poor', 'poor', 'JJ', 'I-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('capability', 'capability', 'NN', 'I-NP', 'O')
('when', 'when', 'WRB', 'B-ADVP', 'O')
('screening', 'screen', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('high', 'high', 'JJ', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('affinities.', 'affinities.', 'NN', 'I-NP', 'O')
Obtaining accurate     structural     information     on     the binding pose of a ligand at a binding site is essential to the design of optimized lead compounds in computer-aided drug discovery.
('Obtaining', 'Obtain', 'VBG', 'B-VP', 'O')
('accurate', 'accurate', 'JJ', 'B-NP', 'O')
('structural', 'structural', 'JJ', 'I-NP', 'O')
('information', 'information', 'NN', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('pose', 'pose', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('binding', 'bind', 'VBG', 'I-NP', 'B-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('is', 'be', 'VBZ', 'B-VP', 'O')
('essential', 'essential', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('design', 'design', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('optimized', 'optimize', 'VBN', 'B-NP', 'O')
('lead', 'lead', 'JJ', 'I-NP', 'O')
('compounds', 'compound', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('computer-aided', 'computer-aided', 'JJ', 'B-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery.', 'discovery.', 'NN', 'I-NP', 'O')
An accurate calculation of atomic partial charges of a ligand in the field of the receptor would result in improved docking results.
('An', 'An', 'DT', 'B-NP', 'O')
('accurate', 'accurate', 'JJ', 'I-NP', 'O')
('calculation', 'calculation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('atomic', 'atomic', 'JJ', 'B-NP', 'O')
('partial', 'partial', 'JJ', 'I-NP', 'O')
('charges', 'charge', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('field', 'field', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('would', 'would', 'MD', 'B-VP', 'O')
('result', 'result', 'VB', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('improved', 'improve', 'VBN', 'B-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('results.', 'results.', 'NNS', 'I-NP', 'O')
We tested whether charges obtained from the QM/MM calculation for ligand/PPARystructure would provide a more precise binding pose compared to the standard docking method, which relies on the default force-field charges.
('We', 'We', 'PRP', 'B-NP', 'O')
('tested', 'test', 'VBD', 'B-VP', 'O')
('whether', 'whether', 'IN', 'B-SBAR', 'O')
('charges', 'charge', 'NNS', 'B-NP', 'O')
('obtained', 'obtain', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('QM/MM', 'QM/MM', 'NN', 'I-NP', 'O')
('calculation', 'calculation', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ligand/PPARy', 'ligand/PPARy', 'NN', 'B-NP', 'O')
('structure', 'structure', 'NN', 'I-NP', 'O')
('would', 'would', 'MD', 'B-VP', 'O')
('provide', 'provide', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('more', 'more', 'RBR', 'I-NP', 'O')
('precise', 'precise', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('pose', 'pose', 'NN', 'I-NP', 'O')
('compared', 'compare', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('method,', 'method,', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('relies', 'rely', 'VBZ', 'B-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('default', 'default', 'NN', 'I-NP', 'O')
('force-field', 'force-field', 'JJ', 'I-NP', 'O')
('charges.', 'charges.', 'NNS', 'I-NP', 'O')
The results of a standard docking run and a QPLD run for a cognate ligand of PPARy are shown in Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('run', 'run', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('QPLD', 'QPLD', 'NN', 'I-NP', 'B-DNA')
('run', 'run', 'VBN', 'B-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('cognate', 'cognate', 'JJ', 'I-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('PPARy', 'PPARy', 'NN', 'B-NP', 'B-protein')
('are', 'be', 'VBP', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Fig.', 'Fig.', 'NNP', 'B-NP', 'O')
2.
('2.', '2.', 'LS', 'B-LST', 'O')
The RMSD (Root Mean Square Deviation) value between crystal and docked poses of the cognate ligand was 2.17 A from the standard docking run, while the QPLD method returned a significantly improved RMSD value of 0.86 A.
('The', 'The', 'DT', 'B-NP', 'O')
('RMSD', 'RMSD', 'NNP', 'I-NP', 'O')
('(Root', '(Root', 'NNP', 'I-NP', 'O')
('Mean', 'Mean', 'NNP', 'I-NP', 'O')
('Square', 'Square', 'NNP', 'I-NP', 'O')
('Deviation)', 'Deviation)', 'NNP', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('crystal', 'crystal', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('docked', 'dock', 'VBD', 'B-VP', 'O')
('poses', 'pose', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cognate', 'cognate', 'JJ', 'I-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('2.17', '2.17', 'CD', 'B-NP', 'O')
('A', 'A', 'NN', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('standard', 'standard', 'JJ', 'I-NP', 'O')
('docking', 'docking', 'NN', 'I-NP', 'O')
('run,', 'run,', 'NN', 'I-NP', 'O')
('while', 'while', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('QPLD', 'QPLD', 'NN', 'I-NP', 'O')
('method', 'method', 'NN', 'I-NP', 'O')
('returned', 'return', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('significantly', 'significantly', 'RB', 'I-NP', 'O')
('improved', 'improve', 'VBN', 'I-NP', 'O')
('RMSD', 'RMSD', 'NN', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('0.86', '0.86', 'CD', 'B-NP', 'O')
('A.', 'A.', 'NN', 'I-NP', 'O')
Atomic charge values in parts of the ligand structure were revealed (Fig.
('Atomic', 'Atomic', 'JJ', 'B-NP', 'O')
('charge', 'charge', 'NN', 'I-NP', 'O')
('values', 'value', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('parts', 'part', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('structure', 'structure', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('revealed', 'reveal', 'VBN', 'I-VP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
3).
('3).', '3).', 'LS', 'B-LST', 'O')
We confirmed the existence of significant changes in partial charges by using the QM/MM   calculation   of the QPLD run.
('We', 'We', 'PRP', 'B-NP', 'O')
('confirmed', 'confirm', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('existence', 'existence', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('significant', 'significant', 'JJ', 'B-NP', 'O')
('changes', 'change', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('partial', 'partial', 'JJ', 'B-NP', 'O')
('charges', 'charge', 'NNS', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('QM/MM', 'QM/MM', 'NN', 'I-NP', 'O')
('calculation', 'calculation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('QPLD', 'QPLD', 'NN', 'I-NP', 'O')
('run.', 'run.', 'NN', 'I-NP', 'O')
These results indicate that   polarization   effects induced by the field of the receptor can   significantly   affect the final conformation of a ligand bound to   PPARy.
('These', 'These', 'DT', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('indicate', 'indicate', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('polarization', 'polarization', 'NN', 'B-NP', 'O')
('effects', 'effect', 'NNS', 'I-NP', 'O')
('induced', 'induce', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('field', 'field', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('significantly', 'significantly', 'RB', 'I-VP', 'O')
('affect', 'affect', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('final', 'final', 'JJ', 'I-NP', 'O')
('conformation', 'conformation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('ligand', 'ligand', 'NN', 'I-NP', 'O')
('bound', 'bind', 'VBD', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('PPARy.', 'PPARy.', 'NNP', 'B-NP', 'O')
Vte   have therefore demonstrated that an additional   process of   calculating subtle changes in charges, by incorporating environmental polarization effects, considerably improves the accuracy of docking predictions.
('Vte', 'Vte', 'NN', 'B-NP', 'B-protein')
('have', 'have', 'VBP', 'B-VP', 'O')
('therefore', 'therefore', 'RB', 'I-VP', 'O')
('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('additional', 'additional', 'JJ', 'I-NP', 'O')
('process', 'process', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('calculating', 'calculate', 'VBG', 'B-VP', 'O')
('subtle', 'subtle', 'JJ', 'B-NP', 'O')
('changes', 'change', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('charges,', 'charges,', 'NN', 'B-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('incorporating', 'incorporate', 'VBG', 'B-VP', 'O')
('environmental', 'environmental', 'JJ', 'B-NP', 'O')
('polarization', 'polarization', 'NN', 'I-NP', 'O')
('effects,', 'effects,', 'NN', 'I-NP', 'O')
('considerably', 'considerably', 'RB', 'B-ADVP', 'O')
('improves', 'improve', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('accuracy', 'accuracy', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('docking', 'docking', 'NN', 'B-NP', 'O')
('predictions.', 'predictions.', 'NNS', 'I-NP', 'O')
In this article we have introduced several advanced computer-aided drug discovery methodologies for receptor-entricvirtual screening.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('article', 'article', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('introduced', 'introduce', 'VBN', 'I-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('advanced', 'advanced', 'JJ', 'I-NP', 'O')
('computer-aided', 'computer-aided', 'JJ', 'I-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery', 'discovery', 'NN', 'I-NP', 'O')
('methodologies', 'methodology', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('receptor-entric', 'receptor-entric', 'JJ', 'B-NP', 'O')
('virtual', 'virtual', 'JJ', 'I-NP', 'O')
('screening.', 'screening.', 'NN', 'I-NP', 'O')
We have evaluated their reliability using a set of test ligands and two receptor structures belonging to the nuclear receptor superfamily.
('We', 'We', 'PRP', 'B-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('evaluated', 'evaluate', 'VBN', 'I-VP', 'O')
('their', 'their', 'PRP$', 'B-NP', 'O')
('reliability', 'reliability', 'NN', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('set', 'set', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('test', 'test', 'NN', 'B-NP', 'B-protein')
('ligands', 'ligand', 'NNS', 'I-NP', 'I-protein')
('and', 'and', 'CC', 'O', 'O')
('two', 'two', 'CD', 'B-NP', 'O')
('receptor', 'receptor', 'NN', 'I-NP', 'O')
('structures', 'structure', 'NNS', 'I-NP', 'O')
('belonging', 'belong', 'VBG', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nuclear', 'nuclear', 'JJ', 'I-NP', 'B-protein')
('receptor', 'receptor', 'NN', 'I-NP', 'I-protein')
('superfamily.', 'superfamily.', 'NN', 'I-NP', 'O')
Our data suggest that some of these methodologies significantly improve virtual screening efficiency by better prioritizing active compounds, and by more precisely reproducing the crystal pose of cognate ligands.
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('suggest', 'suggest', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('some', 'some', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('methodologies', 'methodology', 'NNS', 'I-NP', 'O')
('significantly', 'significantly', 'RB', 'B-VP', 'O')
('improve', 'improve', 'VBP', 'I-VP', 'O')
('virtual', 'virtual', 'JJ', 'B-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('efficiency', 'efficiency', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('better', 'good', 'JJR', 'B-NP', 'O')
('prioritizing', 'prioritize', 'VBG', 'I-NP', 'O')
('active', 'active', 'JJ', 'I-NP', 'O')
('compounds,', 'compounds,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'B-PP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('more', 'more', 'RBR', 'B-VP', 'O')
('precisely', 'precisely', 'RB', 'I-VP', 'O')
('reproducing', 'reproduce', 'VBG', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('crystal', 'crystal', 'JJ', 'I-NP', 'O')
('pose', 'pose', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('cognate', 'cognate', 'JJ', 'B-NP', 'O')
('ligands.', 'ligands.', 'NNS', 'I-NP', 'O')
Although the current study does not involve a large number of receptors and test sets of compounds, our evaluation data should add valuable information that may enhance the practice of computer- ased drug discovery.
('Although', 'Although', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('current', 'current', 'JJ', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('does', 'do', 'VBZ', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('involve', 'involve', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('large', 'large', 'JJ', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('receptors', 'receptor', 'NNS', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('test', 'test', 'NN', 'I-NP', 'O')
('sets', 'set', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('compounds,', 'compounds,', 'NN', 'B-NP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('evaluation', 'evaluation', 'NN', 'I-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('should', 'should', 'MD', 'B-VP', 'O')
('add', 'add', 'VB', 'I-VP', 'O')
('valuable', 'valuable', 'JJ', 'B-NP', 'O')
('information', 'information', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('may', 'may', 'MD', 'B-VP', 'O')
('enhance', 'enhance', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('practice', 'practice', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('computer-', 'computer-', 'NN', 'B-NP', 'O')
('ased', 'ase', 'VBN', 'I-NP', 'O')
('drug', 'drug', 'NN', 'I-NP', 'O')
('discovery.', 'discovery.', 'NN', 'I-NP', 'O')
